Sign in to view content

Conversion Rates from Nonexudative to Exudative Age-Related Macular Degeneration: An AAO IRIS® Registry Analysis

Dan A Gong, MD

Video
Published 2022

Related

Intravitreal Gene Therapy for Neovascular AMD With ADVM-022: Results of the Phase 1 OPTIC Trial
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2020
One Year and Beyond: Results of Phase 1b Study of KSI-301, an AntiVEGF Antibody Biopolymer Conjugate With Extended Durability, in wAMD, DME, and RVO
Mark R. Barakat, MD
Updates from the Field
2020
Current United States Treatment Patterns for the Treatment of Proliferative Diabetic Retinopathy in the IRIS Registry
Jeremiah Brown, MD, MS, FASRS
Annual Meeting Talks
2020

Category: AMD-Neovascular

See more